Literature DB >> 4191565

Amantadine for Parkinson's disease.

C Fieschi, M Nardini, M Casacchia, M E Tedone.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4191565     DOI: 10.1016/s0140-6736(70)91065-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Solid-state NMR and MD simulations of the antiviral drug amantadine solubilized in DMPC bilayers.

Authors:  Conggang Li; Myunggi Yi; Jun Hu; Huan-Xiang Zhou; Timothy A Cross
Journal:  Biophys J       Date:  2007-09-21       Impact factor: 4.033

Review 2.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

Review 3.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

4.  Proceedings: Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and parkinsonian subjects.

Authors:  D G Jones; J A Lenman; M A Robertson; M J Turnbull
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

5.  Treatment for Parkinsonism, other than levodopa.

Authors: 
Journal:  Br Med J       Date:  1972-03-18

6.  Amantadine sulphate in treating Parkinson's disease: clinical effects, psychometric tests and serum concentrations.

Authors:  M Brenner; A Haass; P Jacobi; K Schimrigk
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

7.  Amantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over study.

Authors:  A Barbeau; H Mars; M I Botez; M Joubert
Journal:  Can Med Assoc J       Date:  1971-07-10       Impact factor: 8.262

8.  Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect.

Authors:  G M Pacifici; M Nardini; P Ferrari; R Latini; C Fieschi; P L Morselli
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

Review 9.  Amantadine in Parkinson's disease.

Authors:  N Crosby; K H Deane; C E Clarke
Journal:  Cochrane Database Syst Rev       Date:  2003
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.